Overview

Safety and Effectiveness of PEG-Intron in HIV-Infected Patients

Status:
Completed
Trial end date:
2000-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if it is effective to give PEG-Intron (PEG-IFN) to HIV-infected patients who are not doing well with their current anti-HIV drug combination (HAART).
Phase:
Phase 2
Details
Lead Sponsor:
Schering-Plough
Treatments:
Peginterferon alfa-2b